Rhinitis in patients treated with a combination of an mTOR inhibitor and an EGFR inhibitor

MeSH terms

• Antineoplastic Combined Chemotherapy Protocols / adverse effects*
• Antineoplastic Combined Chemotherapy Protocols / therapeutic use
• Carcinoma, Non-Small-Cell Lung / drug therapy*
• Carcinoma, Non-Small-Cell Lung / pathology
• Endoscopy
• Epistaxis / chemically induced
• Epistaxis / pathology
• ErbB Receptors / antagonists & inhibitors*
• Follow-Up Studies
• Humans
• Lung Neoplasms / drug therapy*
• Lung Neoplasms / pathology
• Nasal Mucosa / drug effects
• Nasal Mucosa / pathology
• Nasal Obstruction / chemically induced
• Nasal Obstruction / pathology
• Neoplasm Staging
• Rhinitis / chemically induced*
• TOR Serine-Threonine Kinases / antagonists & inhibitors*
• Turbinates / drug effects
• Turbinates / pathology